Meclofenamate (Meclofenamate Sodium) - Summary

MECLOFENAMATE SUMMARY

MECLOFENAMATE SODIUM
CAPSULES, USP
50 mg and 100 mg

Meclofenamate sodium is N-(2,6-dichloro-m-tolyl) anthranilic acid, sodium salt, monohydrate. It is an anti-inflammatory drug for oral administration.

Meclofenamate sodium is indicated for the relief of mild to moderate pain.

Meclofenamate sodium is also indicated for the treatment of primary dysmenorrhea and for the treatment of idiopathic heavy menstrual blood loss (see CLINICAL PHARMACOLOGY and PRECAUTIONS).

Meclofenamate sodium is also indicated for relief of the signs and symptoms of acute and chronic rheumatoid arthritis and osteoarthritis. As with all non-steroidal anti-inflammatory drugs, selection of meclofenamate sodium requires a careful assessment of the benefit/risk ratio (see WARNINGS, PRECAUTIONS and ADVERSE REACTIONS).

Meclofenamate sodium is not recommended in children because adequate studies to demonstrate safety and efficacy have not been carried out.

MECLOFENAMATE NEWS HIGHLIGHTS

Published Studies Related to Meclofenamate

Single dose and multidose analgesic study of ibuprofen and meclofenamate sodium after third molar surgery. [1993.12]

Efficacy of meclofenamate sodium (Meclomen) in the treatment of rapidly progressive periodontitis. [1993.10]

[Analgesic effect of sodium meclofenamate on several painful symptoms] [1993.09]

Efficacy of meclofenamate sodium versus placebo in headache and craniofacial pain. [1993.01]

An attempt at real prophylaxis of primary dysmenorrhea: comparison between meclofenamate sodium and naproxen sodium. [1993]

more>>